News & Blog
Welcome to the Atelerix News & Blog - warm takes on keeping cells happy without the cold, with company updates & research insights (no frostbite required).
Featured articles
From Lab to Market: Recent Advances and Commercialisation of Organoid Technologies
By Sophie Reay Organoids are three-dimensional (3D) tissue cultures derived from stem cells that self-organise into structures that closely […]
Sunil Shah and Dr Catherine Elton join Atelerix’s Board to drive global commercial expansion
Sunil Shah and Dr Catherine Elton join Atelerix’s Board to drive global commercial expansion Industry-leaders Sunil Shah (CEO, o2h […]
Two Years On: Stem Cell Therapy Brings Sustained Vision Improvement Thanks to Alginate-Based Delivery
At Atelerix, we’re proud to support pioneering work that translates innovative science into real-world patient impact. A recent clinical milestone […]
New White Paper Released!
The use of organoids for disease modelling, drug discovery and personalised medicine has become increasingly popular. Processes for the generation […]
Storage of cancer tissue at room temperature using TissueReady™ PLUS
New White Paper Released! The sourcing of primary tissue is vital for many fields of research and is becoming increasingly […]
Atelerix work with RareCan, NovoPath and the Rare Cancer Research Group
Freshly obtained clinical tissue is used for several purposes including advanced diagnostic techniques, basic research and establishing physiologically relevant models for […]
New distributor agreement between Atelerix (UK) and Scintila S.R.O (Czech Republic and Slovakia).
We are proud to announce the beginning of a new distribution agreement with Scintila S.R.O, who will be distributing our […]
GBIP Canada Application Success
Atelerix has been awarded a place on the Global Business Innovation Programme for Biomanufacturing of Biologics and Advanced Therapies in […]
Press Release: Strategic partnership for market expansion
Atelerix Limited, which develops and markets innovative solutions for the storage and transport of cells, tissues, and viruses at hypothermic […]
New Publication Announcement!
Following on from LVPEI’s successful proof of concept studies highlighting the successful use of Atelerix’s technology to distribute a limbal-stromal cell therapy throughout […]
BeadReady™ successfully storing cells for 3D biofabrication – Read our latest publication
Another fantastic publication highlighting one of the multiple applications Atelerix products have within the scientific research and development industry. Anastassia […]
CytoStor™ successfully preserves primary human Liver Sinusoidal Endothelial cells (LSEC)
The liver microenvironment is proving to be a major obstacle to the success of immunotherapy in solid organ tumours. The […]
New Publication Announcement!
Branco et al. have recently published an excellent paper showing the benefits of Atelerix technology in the preservation of Adipose-Derived […]
CytoStor™ & the transport of precious cells
How preservation of urine can impact kidney disease research Background: Each day, 20 people in the UK alone, develop chronic […]
TissueReady™ & Organoid Modelling
Pancreatic cancer is one of the most aggressive and lethal solid tumours. Pancreatic ductal adenocarcinoma (PDAC) describes malignancies of the […]
Atelerix supports lifetime CDT
The EPSRC-SFI Joint Centre for Doctoral Training in Engineered Tissues for Discovery, Industry and Medicine (lifETIME CDT) is a partnership […]
Atelerix presents promising data for the application of its technology LeukoStor™ to CAR-T Cell Therapy Manufacturing
One of the biggest challenges faced by CAR-T Cell manufacturers is the variability among apheresis product, which can negatively impact […]
BeadReady™ & Bioprinting MSC Spheroids
The population of haematopoietic stem cells (HSCs) found in our bone marrow are responsible for repopulating the body with all […]
